Monthly Archives: May 2013

In this issue of Genome Medicine: disease in the microbial jungle, a technology for target enrichment, genomics of osteoporosis and chronic lymphocytic leukemia, and more…

GM logo

The May issue of Genome Medicine features two articles that highlight the role of microbes in human health and disease as part of a recently launched thematic series on this exact topic. Charis Eng muses on the importance of maintaining a healthy microbiome to prevent disease and discusses how microbiome profiles could be used as… Read more »

Journal for ImmunoTherapy of Cancer launches with BioMed Central

Journal for ImmunoTherapy of Cancer

June is Cancer Immunotherapy Awareness Month, an initiative to increase the public’s awareness of the revolutionary new treatment approach. Cancer immunotherapy utilises the immune system to fight the disease and represents the most immediate hope for curing patients with any type of cancer. BioMed Central and the Society for Immunotherapy of Cancer (SITC) are therefore… Read more »

Journal of Intensive Care is now accepting submissions

Journal of Intensive Care_Logo_300dpi

As the field of intensive care medicine advances, maximizing the abilities of medical professionals to treat critical illness becomes more important. They must be able to work individually, cooperatively, and participate in the international exchange of opinion.   Journal of Intensive Care is an open access, peer-reviewed online journal that encompasses all aspects of intensive… Read more »

Infectious Agents & Cancer announces new 'Clinical oncology' section

vaccines and africa istock

Clinical oncology in Western countries is currently characterized by preventative programs (which include early diagnosis), combined treatments (radio-chemo-surgery), reconstructive surgery, and, more recently, by tailored treatment with monoclonal antibodies or specific inhibitors based on newly identified cancer biomarkers. Clinical oncology in the rest of the world, which represents 85.3% of the Earth’s population, has different… Read more »

Changes in leadership for Alzheimer’s Research & Therapy

We are delighted to welcome Dr Philip Scheltens to his new position as one of the Editors-in-Chief of Alzheimer’s Research & Therapy, joining Dr Douglas Galasko (University of California, San Diego, USA) and Dr Todd Golde (University of Florida, USA). Dr Scheltens is replacing Dr Gordon Wilcock (University of Oxford, UK), who is stepping down… Read more »

Celebrating International Clinical Trials Day

On May 20, 1747, James Lind pioneered a scurvy trial on board the HMS Salisbury. Providing some crew members with two oranges and one lemon per day, while others were given cider, vinegar, sulphuric acid or seawater, along with their normal rations, Lind’s experiment is ranked as one of the first clinical trials in the… Read more »